Prof. WANG Wei, Xiangya No. 3 Hospital, part of the Zhongnan University, has harvested series findings in insulin transplanting, which boosts human confidence in combating type I diabetes. Based on extensive basic researches, WANG performed, starting from 1999, heterogeneous insulin transplanting on 20 type I diabetes patients. He transplanted the pig insulin cells into their bodies, and freed them from tortures of the disease.
WANG has made three major contributions to insulin transplanting: 1) creating a safer transplanting method. Currently, a prevailing process in the world is to transplant insulin cells through liver?痵 portal vein, which may cause damages to liver itself. WANG makes the transplanting through liver?痵 artery, which greatly improves safety; 2) Wang and Prof. MO Zhaohui jointly discovered apparent differences between different races, in terms of the adverse effects in anti-repulsion treatment, which led to a desirable and enhanced therapeutic solution for Chinese populations; 3) WANG studied different therapeutic solutions for heterogeneous and homogenous insulin transplanting, and for the first time in the world found special rules for staging an anti-repulsion treatment for heterogeneous transplanting. This creates a new way of thinking in addressing serious shortages of insulin providers. |
